NL-OMON42253已完成4 期
Biomedical interventions for HIV prevention in MSM in Amsterdam: a demonstration project - AMPrEP: Amsterdam PrEP program
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 370
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- 未提供
排除标准
- •One of the following:1. Signs or symptoms of acute HIV infection2. Hepatitis B
- •infection (i.e. HbsAg positive)3. Unlikely, in the opinion of the clinician, to
- •comply with project schedule4. Hypersensitivity for one of the components of
- •fixed combination tablet containing tenofovir and emtricitabine5. Creatinine
- •clearing using cockroft gault formula: < 60 ml/minrolegroepContr
研究者
相似试验
进行中（未招募）
不适用
HIV prevention for men who have sex with men using medicatioprevention of HIV infectionEUCTR2014-002569-32-NLAcademic Medical Center
已完成
不适用
AMPrEP (Amsterdam PrEP project)HIVpreventionPre-exposure prophylaxisNL-OMON22706Academic Medical Center is sponsor. Center for study visits: Public Health service Amsterdam (GGD Amsterdam)370
招募中
不适用
HIV/AIDS prevention research for MSM by development of a card toolAIDSJPRN-UMIN000011340School of Medicine, Keio University3,600
已完成
不适用
CHEMOPROPHYLAXIS FOR THE PREVENTION OF HIV IN ME-Z21 Asymptomatic human immunodeficiency virus [HIV] infection statusAsymptomatic human immunodeficiency virus [HIV] infection statusZ21PER-072-06INSTITUTO NACIONAL DE ALERGIAS Y ENFERMEDADES INFECCIOSAS DE LOS ESTADOS UNIDOS, INSTITUTOS J. DAVID GLADSTONE, FAMILY HEALTH INTERNATIONAL - FHI 360°,2,339
招募中
不适用
PROJECT ¿SABES?”PER-066-14Centro de Investigacion del Cancer Fred Hutchinson, Estados Unidos,2,138